The functional network of ion channels in T lymphocytes.

Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu Rev Immunol (2010) 5.11

Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy. Cell (2011) 2.93

Ion channels in innate and adaptive immunity. Annu Rev Immunol (2015) 1.99

How the TCR balances sensitivity and specificity for the recognition of self and pathogens. Nat Immunol (2012) 1.80

A novel EF-hand protein, CRACR2A, is a cytosolic Ca2+ sensor that stabilizes CRAC channels in T cells. Nat Cell Biol (2010) 1.79

Ion channels and transporters in lymphocyte function and immunity. Nat Rev Immunol (2012) 1.74

Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance. Proc Natl Acad Sci U S A (2013) 1.64

Ionic immune suppression within the tumour microenvironment limits T cell effector function. Nature (2016) 1.63

Mitochondrial shape changes: orchestrating cell pathophysiology. EMBO Rep (2010) 1.61

Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases. Toxicon (2011) 1.59

The roles of K(+) channels in cancer. Nat Rev Cancer (2013) 1.46

Immunodeficiency due to mutations in ORAI1 and STIM1. Clin Immunol (2010) 1.39

Voltage-gated proton channels: molecular biology, physiology, and pathophysiology of the H(V) family. Physiol Rev (2013) 1.35

ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis. Proc Natl Acad Sci U S A (2011) 1.35

Potassium channels in cell cycle and cell proliferation. Philos Trans R Soc Lond B Biol Sci (2014) 1.29

Subunit stoichiometry of human Orai1 and Orai3 channels in closed and open states. Proc Natl Acad Sci U S A (2011) 1.28

Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease. J Pharmacol Exp Ther (2012) 1.19

A voltage-gated sodium channel is essential for the positive selection of CD4(+) T cells. Nat Immunol (2012) 1.15

Pathogenesis of allergic airway inflammation. Curr Allergy Asthma Rep (2010) 1.11

Orai1, STIM1, and their associating partners. J Physiol (2012) 1.11

Molecular biophysics of Orai store-operated Ca2+ channels. Biophys J (2015) 1.09

Calpain 2 controls turnover of LFA-1 adhesions on migrating T lymphocytes. PLoS One (2010) 1.08

Orai1-NFAT signalling pathway triggered by T cell receptor stimulation. Mol Cells (2013) 1.05

Endothelial small-conductance and intermediate-conductance KCa channels: an update on their pharmacology and usefulness as cardiovascular targets. J Cardiovasc Pharmacol (2013) 1.05

Nucleoside diphosphate kinase B knock-out mice have impaired activation of the K+ channel KCa3.1, resulting in defective T cell activation. J Biol Chem (2010) 1.00

The voltage-dependent K(+) channels Kv1.3 and Kv1.5 in human cancer. Front Physiol (2013) 1.00

A microarray platform-independent classification tool for cell of origin class allows comparative analysis of gene expression in diffuse large B-cell lymphoma. PLoS One (2013) 0.99

Complex role of STIM1 in the activation of store-independent Orai1/3 channels. J Gen Physiol (2014) 0.99

Physiology of potassium channels in the inner membrane of mitochondria. Pflugers Arch (2011) 0.99

The Lymphocyte Potassium Channels Kv1.3 and KCa3.1 as Targets for Immunosuppression. Drug Dev Res (2011) 0.98

Kv1.3 deletion biases T cells toward an immunoregulatory phenotype and renders mice resistant to autoimmune encephalomyelitis. J Immunol (2012) 0.98

Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells. EMBO Mol Med (2012) 0.96

Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells. Mol Pharmacol (2012) 0.96

Natural products and ion channel pharmacology. Future Med Chem (2010) 0.96

Kv1.3 is the exclusive voltage-gated K+ channel of platelets and megakaryocytes: roles in membrane potential, Ca2+ signalling and platelet count. J Physiol (2010) 0.95

Selective activation of KCa3.1 and CRAC channels by P2Y2 receptors promotes Ca(2+) signaling, store refilling and migration of rat microglial cells. PLoS One (2013) 0.94

Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma. J Biol Chem (2014) 0.94

The immunological synapse: a dynamic platform for local signaling. J Clin Immunol (2010) 0.94

Involvement of dominant-negative spliced variants of the intermediate conductance Ca2+-activated K+ channel, K(Ca)3.1, in immune function of lymphoid cells. J Biol Chem (2011) 0.93

Selective inhibition of CCR7(-) effector memory T cell activation by a novel peptide targeting Kv1.3 channel in a rat experimental autoimmune encephalomyelitis model. J Biol Chem (2012) 0.93

Modulation of T Cell Metabolism and Function through Calcium Signaling. Front Immunol (2013) 0.93

Tripartite motif containing protein 27 negatively regulates CD4 T cells by ubiquitinating and inhibiting the class II PI3K-C2β. Proc Natl Acad Sci U S A (2011) 0.93

KCa3.1 and TRPM7 channels at the uropod regulate migration of activated human T cells. PLoS One (2012) 0.89

Disruption of kv1.3 channel forward vesicular trafficking by hypoxia in human T lymphocytes. J Biol Chem (2011) 0.89

Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes. PLoS One (2013) 0.89

The TRPM6/EGF pathway is downregulated in a rat model of cisplatin nephrotoxicity. PLoS One (2013) 0.89

Microglial KCa3.1 Channels as a Potential Therapeutic Target for Alzheimer's Disease. Int J Alzheimers Dis (2012) 0.89

CD95 triggers Orai1-mediated localized Ca2+ entry, regulates recruitment of protein kinase C (PKC) β2, and prevents death-inducing signaling complex formation. Proc Natl Acad Sci U S A (2011) 0.88

The Olfactory Bulb: A Metabolic Sensor of Brain Insulin and Glucose Concentrations via a Voltage-Gated Potassium Channel. Results Probl Cell Differ (2010) 0.87

Selective targeting of the α5-subunit of GABAA receptors relaxes airway smooth muscle and inhibits cellular calcium handling. Am J Physiol Lung Cell Mol Physiol (2015) 0.87

Potent suppression of Kv1.3 potassium channel and IL-2 secretion by diphenyl phosphine oxide-1 in human T cells. PLoS One (2013) 0.86

Peripherally induced human regulatory T cells uncouple Kv1.3 activation from TCR-associated signaling. Eur J Immunol (2011) 0.86

Detailed examination of Mg2+ and pH sensitivity of human TRPM7 channels. Am J Physiol Cell Physiol (2012) 0.86

Trafficking of intermediate (KCa3.1) and small (KCa2.x) conductance, Ca(2+)-activated K(+) channels: a novel target for medicinal chemistry efforts? ChemMedChem (2012) 0.86

T cells in vascular inflammatory diseases. Front Immunol (2014) 0.85

Modulation of Kv1.3 channels by protein kinase A I in T lymphocytes is mediated by the disc large 1-tyrosine kinase Lck complex. Am J Physiol Cell Physiol (2012) 0.84

Ion channels in hematopoietic and mesenchymal stem cells. Stem Cells Int (2012) 0.84

Blockade of Kv1.3 channels ameliorates radiation-induced brain injury. Neuro Oncol (2013) 0.84

Ca(2+) influx in T cells: how many ca(2+) channels? Front Immunol (2013) 0.84

Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases. FASEB J (2014) 0.84

Physiological role of Kv1.3 channel in T lymphocyte cell investigated quantitatively by kinetic modeling. PLoS One (2014) 0.84

Modulation of voltage-gated K+ channels by the sodium channel β1 subunit. Proc Natl Acad Sci U S A (2012) 0.84

Selective inhibition of KCa3.1 channels mediates adenosine regulation of the motility of human T cells. J Immunol (2013) 0.84

Orai1 function is essential for T cell homing to lymph nodes. J Immunol (2013) 0.83

Tuning voltage-gated channel activity and cellular excitability with a sphingomyelinase. J Gen Physiol (2013) 0.82

Kv1.3 channels mark functionally competent CD8+ tumor infiltrating lymphocytes in head and neck cancer. Cancer Res (2016) 0.82

Potassium Channels Blockers from the Venom of Androctonus mauretanicus mauretanicus. J Toxicol (2012) 0.82

The role of PSD-95 in the rearrangement of Kv1.3 channels to the immunological synapse. Pflugers Arch (2013) 0.82

Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes. J Biol Chem (2012) 0.82

Regulation of endogenous and heterologous Ca²⁺ release-activated Ca²⁺ currents by pH. Cell Calcium (2014) 0.82

Sensitivity of TRPM7 channels to Mg2+ characterized in cell-free patches of Jurkat T lymphocytes. Am J Physiol Cell Physiol (2012) 0.82

The antibody targeting the E314 peptide of human Kv1.3 pore region serves as a novel, potent and specific channel blocker. PLoS One (2012) 0.82

Ion channels and anti-cancer immunity. Philos Trans R Soc Lond B Biol Sci (2014) 0.82

Molecular mechanisms of STIM/Orai communication. Am J Physiol Cell Physiol (2016) 0.82

Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions. Nat Commun (2017) 0.82

Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis. J Crohns Colitis (2014) 0.81

Recombinant expression of margatoxin and agitoxin-2 in Pichia pastoris: an efficient method for production of KV1.3 channel blockers. PLoS One (2012) 0.81

The role of Orai-STIM calcium channels in melanocytes and melanoma. J Physiol (2016) 0.81

TASK-2: a K2P K(+) channel with complex regulation and diverse physiological functions. Front Physiol (2013) 0.81

Role of the K(Ca)3.1 K+ channel in auricular lymph node CD4+ T-lymphocyte function of the delayed-type hypersensitivity model. Br J Pharmacol (2013) 0.81

Protein kinase D orchestrates the activation of DRAK2 in response to TCR-induced Ca2+ influx and mitochondrial reactive oxygen generation. J Immunol (2010) 0.81

Functionalized liposomes loaded with siRNAs targeting ion channels in effector memory T cells as a potential therapy for autoimmunity. Biomaterials (2013) 0.81

Ca(2+) signaling in T-cell subsets with a focus on the role of cav1 channels: possible implications in therapeutics. Front Immunol (2013) 0.81

Kv1.5 in the immune system: the good, the bad, or the ugly? Front Physiol (2010) 0.81

Transcriptional remodeling of ion channel subunits by flow adaptation in human coronary artery endothelial cells. J Vasc Res (2011) 0.80

KCa3.1/IK1 Channel Regulation by cGMP-Dependent Protein Kinase (PKG) via Reactive Oxygen Species and CaMKII in Microglia: An Immune Modulating Feedback System? Front Immunol (2015) 0.80

Use of Kv1.3 blockers for inflammatory skin conditions. Curr Med Chem (2010) 0.80

Immunosuppression by N-methyl-D-aspartate receptor antagonists is mediated through inhibition of Kv1.3 and KCa3.1 channels in T cells. Mol Cell Biol (2013) 0.80

The role of transient receptor potential vanilloid type-2 ion channels in innate and adaptive immune responses. Front Immunol (2013) 0.80

What is the evidence for the role of TRP channels in inflammatory and immune cells? Br J Pharmacol (2016) 0.80

The C-terminus SH3-binding domain of Kv1.3 is required for the actin-mediated immobilization of the channel via cortactin. Mol Biol Cell (2015) 0.79

Potassium channel Kv1.3 is highly expressed by microglia in human Alzheimer's disease. J Alzheimers Dis (2015) 0.79

The Ca²⁺-activated K⁺ channel KCa3.1 as a potential new target for the prevention of allograft vasculopathy. PLoS One (2013) 0.79

The functional contribution of calcium ion flux heterogeneity in T cells. Immunol Cell Biol (2015) 0.79

Cell biology. How to STIMulate calcium channels. Science (2010) 0.79

Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis--xenograft model. J Autoimmun (2014) 0.79

Targeting the ion channel Kv1.3 with scorpion venom peptides engineered for potency, selectivity, and half-life. J Biol Chem (2014) 0.79

Blood-brain barrier KCa3.1 channels: evidence for a role in brain Na uptake and edema in ischemic stroke. Stroke (2014) 0.79

Store-operated CRAC channel inhibitors: opportunities and challenges. Future Med Chem (2016) 0.79

Targeting proliferation of chronic lymphocytic leukemia (CLL) cells through KCa3.1 blockade. Leukemia (2014) 0.79

Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch (1981) 134.60

A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature (2006) 14.78

STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Curr Biol (2005) 14.53

STIM1, an essential and conserved component of store-operated Ca2+ channel function. J Cell Biol (2005) 13.11

T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature (2004) 11.14

Of mice and not men: differences between mouse and human immunology. J Immunol (2004) 10.61

Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature (1992) 10.22

Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature (1997) 9.99

CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. Science (2006) 9.61

Calcium oscillations increase the efficiency and specificity of gene expression. Nature (1998) 9.19

STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane. Nature (2005) 8.96

Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science (2002) 8.63

Orai1 is an essential pore subunit of the CRAC channel. Nature (2006) 8.60

TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature (2008) 8.40

Genome-wide RNAi screen of Ca(2+) influx identifies genes that regulate Ca(2+) release-activated Ca(2+) channel activity. Proc Natl Acad Sci U S A (2006) 7.26

Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai. Nature (2006) 7.22

STIM1 clusters and activates CRAC channels via direct binding of a cytosolic domain to Orai1. Cell (2009) 6.92

Ca2+ store depletion causes STIM1 to accumulate in ER regions closely associated with the plasma membrane. J Cell Biol (2006) 6.88

Calcium release-activated calcium current in rat mast cells. J Physiol (1993) 6.33

Amplification of CRAC current by STIM1 and CRACM1 (Orai1). Nat Cell Biol (2006) 6.31

Mitogen-regulated Ca2+ current of T lymphocytes is activated by depletion of intracellular Ca2+ stores. Proc Natl Acad Sci U S A (1993) 6.27

CRACM1 multimers form the ion-selective pore of the CRAC channel. Curr Biol (2006) 6.02

STIM1 carboxyl-terminus activates native SOC, I(crac) and TRPC1 channels. Nat Cell Biol (2006) 5.68

Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol (2007) 5.62

The elementary unit of store-operated Ca2+ entry: local activation of CRAC channels by STIM1 at ER-plasma membrane junctions. J Cell Biol (2006) 5.58

LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature (2001) 5.52

Large store-operated calcium selective currents due to co-expression of Orai1 or Orai2 with the intracellular calcium sensor, Stim1. J Biol Chem (2006) 5.32

Live-cell imaging reveals sequential oligomerization and local plasma membrane targeting of stromal interaction molecule 1 after Ca2+ store depletion. Proc Natl Acad Sci U S A (2007) 5.31

Physiology of cell volume regulation in vertebrates. Physiol Rev (2009) 5.11

Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes. J Exp Med (2004) 5.08

The molecular choreography of a store-operated calcium channel. Nature (2007) 4.80

SOAR and the polybasic STIM1 domains gate and regulate Orai channels. Nat Cell Biol (2009) 4.73

Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis? Nature (1984) 4.70

TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science (2001) 4.33

Mitogen-induced oscillations of cytosolic Ca2+ and transmembrane Ca2+ current in human leukemic T cells. Cell Regul (1989) 4.28

Autonomous T cell trafficking examined in vivo with intravital two-photon microscopy. Proc Natl Acad Sci U S A (2003) 4.22

Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nat Chem Biol (2006) 4.20

Dynamic coupling of the putative coiled-coil domain of ORAI1 with STIM1 mediates ORAI1 channel activation. J Biol Chem (2008) 4.20

A voltage-gated potassium channel in human T lymphocytes. J Physiol (1985) 4.16

Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7. Cell (2003) 4.15

Gene regulation mediated by calcium signals in T lymphocytes. Nat Immunol (2001) 4.09

Two-photon tissue imaging: seeing the immune system in a fresh light. Nat Rev Immunol (2002) 4.01

Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci U S A (2000) 4.01

Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells. PLoS Biol (2005) 4.01

T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node. Proc Natl Acad Sci U S A (2004) 3.99

PIP2 is a necessary cofactor for ion channel function: how and why? Annu Rev Biophys (2008) 3.89

Biochemical and functional characterization of Orai proteins. J Biol Chem (2007) 3.87

Rapid inactivation of depletion-activated calcium current (ICRAC) due to local calcium feedback. J Gen Physiol (1995) 3.75

Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat Immunol (2005) 3.70

Oligomerization of STIM1 couples ER calcium depletion to CRAC channel activation. Nature (2008) 3.67

STIM1: a novel phosphoprotein located at the cell surface. Biochim Biophys Acta (2000) 3.67

Immunocyte Ca2+ influx system mediated by LTRPC2. Science (2001) 3.64

The TRPM7 channel is inactivated by PIP(2) hydrolysis. Nat Cell Biol (2002) 3.63

Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus. Neuron (2001) 3.51

STIM1 heteromultimerizes TRPC channels to determine their function as store-operated channels. Nat Cell Biol (2007) 3.47

The CRAC channel consists of a tetramer formed by Stim-induced dimerization of Orai dimers. Nature (2008) 3.46

Structural and mechanistic insights into STIM1-mediated initiation of store-operated calcium entry. Cell (2008) 3.43

Separation and characterization of currents through store-operated CRAC channels and Mg2+-inhibited cation (MIC) channels. J Gen Physiol (2002) 3.39

Polarity of T cell shape, motility, and sensitivity to antigen. Immunity (1996) 3.33

Differential clustering of CD4 and CD3zeta during T cell recognition. Science (2000) 3.30

p62, a phosphotyrosine-independent ligand of the SH2 domain of p56lck, belongs to a new class of ubiquitin-binding proteins. J Biol Chem (1996) 3.27

Measurement of cytosolic free Ca2+ in individual small cells using fluorescence microscopy with dual excitation wavelengths. Cell Calcium (1985) 3.23

STIMulating store-operated Ca(2+) entry. Nat Cell Biol (2009) 3.18

Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci U S A (2006) 3.13

A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci U S A (1997) 3.12

K+ channels as targets for specific immunomodulation. Trends Pharmacol Sci (2004) 3.12

CRACM1, CRACM2, and CRACM3 are store-operated Ca2+ channels with distinct functional properties. Curr Biol (2007) 3.12

Functional stoichiometry of the unitary calcium-release-activated calcium channel. Proc Natl Acad Sci U S A (2008) 3.07

Mitochondrial regulation of store-operated calcium signaling in T lymphocytes. J Cell Biol (1997) 3.04

The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. J Clin Invest (2003) 3.02

Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation. J Immunol (2001) 3.00

C-type inactivation of a voltage-gated K+ channel occurs by a cooperative mechanism. Biophys J (1995) 2.97

A Cytosolic Homomerization and a Modulatory Domain within STIM1 C Terminus Determine Coupling to ORAI1 Channels. J Biol Chem (2009) 2.97

The calcium current activated by T cell receptor and store depletion in human lymphocytes is absent in a primary immunodeficiency. J Biol Chem (1994) 2.92

K channels in T lymphocytes: a patch clamp study using monoclonal antibody adhesion. Nature (1984) 2.89

Aggregation of STIM1 underneath the plasma membrane induces clustering of Orai1. Biochem Biophys Res Commun (2006) 2.89

Choreography of cell motility and interaction dynamics imaged by two-photon microscopy in lymphoid organs. Annu Rev Immunol (2008) 2.86

Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J Biol Chem (2000) 2.85

Calcium oscillations regulate thymocyte motility during positive selection in the three-dimensional thymic environment. Nat Immunol (2005) 2.82

TEA prevents inactivation while blocking open K+ channels in human T lymphocytes. Biophys J (1989) 2.82

Store-dependent and -independent modes regulating Ca2+ release-activated Ca2+ channel activity of human Orai1 and Orai3. J Biol Chem (2008) 2.75

STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med (2009) 2.72

Dynamics of thymocyte-stromal cell interactions visualized by two-photon microscopy. Science (2002) 2.72

Orai1 subunit stoichiometry of the mammalian CRAC channel pore. J Physiol (2007) 2.69

Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc Natl Acad Sci U S A (2001) 2.63

Distinct properties of CRAC and MIC channels in RBL cells. J Gen Physiol (2002) 2.59

Deletion of Trpm7 disrupts embryonic development and thymopoiesis without altering Mg2+ homeostasis. Science (2008) 2.59

Calcium inhibition and calcium potentiation of Orai1, Orai2, and Orai3 calcium release-activated calcium channels. J Biol Chem (2007) 2.58

A store-operated calcium channel in Drosophila S2 cells. J Gen Physiol (2004) 2.54

Voltage-gated potassium channels are required for human T lymphocyte activation. J Exp Med (1984) 2.54

Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion. J Exp Med (2005) 2.54

The TRPM7 ion channel functions in cholinergic synaptic vesicles and affects transmitter release. Neuron (2006) 2.50

Hair loss and defective T- and B-cell function in mice lacking ORAI1. Mol Cell Biol (2008) 2.50

Identification of stromal cell products that interact with pre-B cells. J Cell Biol (1996) 2.46

Intracellular calcium dependence of gene expression in single T lymphocytes. Proc Natl Acad Sci U S A (1994) 2.42

Functional TRPM7 channels accumulate at the plasma membrane in response to fluid flow. Circ Res (2005) 2.40

Slow calcium-dependent inactivation of depletion-activated calcium current. Store-dependent and -independent mechanisms. J Biol Chem (1995) 2.38

hSK4, a member of a novel subfamily of calcium-activated potassium channels. Proc Natl Acad Sci U S A (1997) 2.31

STIM1-Orai1 interactions and Orai1 conformational changes revealed by live-cell FRET microscopy. J Physiol (2008) 2.29

Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block. Immunity (2008) 2.23

International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev (2005) 3.50

Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci U S A (2006) 3.13

The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. J Clin Invest (2003) 3.02

Induction and monitoring of adoptive delayed-type hypersensitivity in rats. J Vis Exp (2007) 2.61

International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels. Pharmacol Rev (2005) 2.39

Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block. Immunity (2008) 2.23

Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases. Mol Pharmacol (2005) 2.08

International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channels. Pharmacol Rev (2003) 2.05

Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis. Circulation (2003) 1.95

Induction and monitoring of active delayed type hypersensitivity (DTH) in rats. J Vis Exp (2007) 1.94

The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans. J Clin Invest (2008) 1.82

The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain. Proc Natl Acad Sci U S A (2005) 1.69

K+ channel expression during B cell differentiation: implications for immunomodulation and autoimmunity. J Immunol (2004) 1.65

Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance. Proc Natl Acad Sci U S A (2013) 1.64

Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases. Toxicon (2011) 1.59

Induction and clinical scoring of chronic-relapsing experimental autoimmune encephalomyelitis. J Vis Exp (2007) 1.57

Potassium channels as therapeutic targets for autoimmune disorders. Curr Opin Drug Discov Devel (2003) 1.52

Potassium channels, memory T cells, and multiple sclerosis. Neuroscientist (2005) 1.32

Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators. Mol Pharmacol (2004) 1.31

Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia. J Clin Invest (2004) 1.29

SKCa channels mediate the medium but not the slow calcium-activated afterhyperpolarization in cortical neurons. J Neurosci (2004) 1.27

Kv1.3 potassium channels as a therapeutic target in multiple sclerosis. Expert Opin Ther Targets (2009) 1.24

A novel fluorescent toxin to detect and investigate Kv1.3 channel up-regulation in chronically activated T lymphocytes. J Biol Chem (2003) 1.22

Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis. Nat Commun (2011) 1.19

Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease. J Pharmacol Exp Ther (2012) 1.19

The D-diastereomer of ShK toxin selectively blocks voltage-gated K+ channels and inhibits T lymphocyte proliferation. J Biol Chem (2007) 1.07

Mutating a critical lysine in ShK toxin alters its binding configuration in the pore-vestibule region of the voltage-gated potassium channel, Kv1.3. Biochemistry (2002) 1.02

Characterisation of the human voltage-gated potassium channel gene, KCNA7, a candidate gene for inherited cardiac disorders, and its exclusion as cause of progressive familial heart block I (PFHBI). Eur J Hum Genet (2002) 1.01

Kv1.3 deletion biases T cells toward an immunoregulatory phenotype and renders mice resistant to autoimmune encephalomyelitis. J Immunol (2012) 0.98

Potassium channel modulation by a toxin domain in matrix metalloprotease 23. J Biol Chem (2009) 0.97

SK3-1C, a dominant-negative suppressor of SKCa and IKCa channels. J Biol Chem (2003) 0.97

18F-Fallypride PET of pancreatic islets: in vitro and in vivo rodent studies. J Nucl Med (2011) 0.96

Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells. EMBO Mol Med (2012) 0.96

Modulation of mouse Paneth cell alpha-defensin secretion by mIKCa1, a Ca2+-activated, intermediate conductance potassium channel. J Biol Chem (2001) 0.94

Immunohistochemistry: paraffin sections using the Vectastain ABC kit from vector labs. J Vis Exp (2007) 0.92

Shaker-related potassium channels in the central medial nucleus of the thalamus are important molecular targets for arousal suppression by volatile general anesthetics. J Neurosci (2013) 0.89

Preparing T cell growth factor from rat splenocytes. J Vis Exp (2007) 0.87

Isolation of mononuclear cells from the central nervous system of rats with EAE. J Vis Exp (2007) 0.87

Drawing blood from rats through the saphenous vein and by cardiac puncture. J Vis Exp (2007) 0.87

Enrichment of NK cells from human blood with the RosetteSep kit from StemCell technologies. J Vis Exp (2007) 0.84

Blockade of Kv1.3 channels ameliorates radiation-induced brain injury. Neuro Oncol (2013) 0.84

Modulation of voltage-gated K+ channels by the sodium channel β1 subunit. Proc Natl Acad Sci U S A (2012) 0.84

Mouse adrenal chromaffin cell isolation. J Vis Exp (2007) 0.79

Intracellular trafficking of the KV1.3 potassium channel is regulated by the prodomain of a matrix metalloprotease. J Biol Chem (2013) 0.78

Therapeutic potential of peptide toxins that target ion channels. Inflamm Allergy Drug Targets (2011) 0.77

Imaging effector memory T cells in the ear after induction of adoptive DTH. J Vis Exp (2008) 0.76